Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for February 2008
February 1, 2008
- The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis
- Pooled Phase 3 Study of Nplate (Romiplostim) in Adult Patients with Chronic ITP Published in The Lancet
- New Findings Show Enbrel (etanercept) Significantly Reduced Levels of C-Reactive Protein, a Marker of Inflammation, in Patients with Moderate to Severe Plaque Psoriasis
- MediciNova's MN-166 Reduces Persistent Black Hole Formation in Multiple Sclerosis Patients
- Obagi Medical Products' Solubilized Benzoyl Peroxide Provides Clinically Significant Lesion Reduction for Mild to Moderately Severe Acne
- Data Demonstrate that Obagi Medical Products' Condition & Enhance Skin Care System is an Effective Complement to Facial Rejuvenation Procedures
- Researchers Find Biological Factors That May Drive Prostate Tumor Aggressiveness in African-American Men
- Analytical Results for Women from Large Scale Clinical Trial MEGA Study Employing the Hypercholesterolemia Drug Mevalotin® Published
- New Data for Achillion's Elvucitabine Demonstrate Drug's Safety, Efficacy and Suitability for Combination Therapy in HIV-Infected Patients
- Prostate Cancer: Watchful Wait or Vaccinate?
- NexMed Announces Presentation of Data at the 66th Annual Meeting of the American Academy of Dermatology
- Observational Data Show Transfusion Patterns in Chemotherapy-Induced Anemia Patients Receiving Erythropoiesis-Stimulating Agents
- Neuro-Hitech Reports Cognitive Improvement From Phase Two Clinical Trial of Huperzine A In Alzheimer's Disease Patients
- Heart Disease Deaths Continue to Decline in American Women
- Remicade-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body
February 4, 2008
- Clinical Data Reported on Celgene Compound Apremilast (CC-10004) Evaluating Efficacy, Safety and Quality of Life Improvement for Psoriasis Patients
- NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
- IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
- BioLineRx Announces Positive Results From Phase 2a Trial of BL-1020, a GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia
- Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
- ReachMD Broadcasts First-of-its-Kind Physician Peer-Peer Discussion on ENHANCE Trial
- Ustekinumab (CNTO 1275) Phase 3 Data Show Long-Term Improvement Of Chronic Plaque Psoriasis
- Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder
- Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
- Penwest Announces Results of Phase IIa Clinical Study of Nalbuphine ER
- PhytoMedical Bolsters Cancer Research Following Favorable Results
- St. Jude Finds Risk Factors for Severe RSV Infection in Immunocompromised Children
February 5, 2008
- Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
- PTC Therapeutics Announces Publication of Preclinical Data in PNAS
- Savient Reports Additional Positive Trial Data for Secondary Endpoints from Puricase (pegloticase) Phase 3 Studies
- ATryn(R) Meets Primary Endpoint
- Hollis-Eden Pharmaceuticals Presents Additional Data Demonstrating Activity of Apoptone in Inducing Cancer Cell Death
- Ceremed's Ostene Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
- Avanir Announces Progress on Zenvia Development
- Cleviprex Demonstrated Rapid, Precise Blood Pressure Control in High-Risk Patients, According to New Analyses
- Multiple Dose Clinical Trial of TorreyPines Therapeutics' Tezampanel Demonstrates Compound is Safe and Well-Tolerated
- Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells
- John Wayne Cancer Institute Researchers Show that a Key Protein Appears to Enable Spread of Melanoma to the Small Intestine
February 6, 2008
- Artes Medical's 5-Year Safety and Efficacy Data Presented at the American Academy of Dermatology Conference
- Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
- Biovitrum and Symphogen have Successfully Completed Phase I Clinical Trial with Recombinant Polyclonal Antibody
- Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
- VIR201 Phase IIa Trial Results Now Published in Peer Reviewed Scientific Journal – Human Vaccines
- Leading Investigators Highlight Advances in Photodynamic Therapy at the American Academy of Dermatology Annual Meeting
- Nymox Announces Positive Results from New Multi-Center U.S. Study of NX-1207 For BPH
- Intercell’s Therapeutic Hepatitis C Vaccine Meets Primary Endpoints in Phase II
- Molecular Therapy Succeeds in Preventing Craniofacial Birth Defect in Mice
- Dr. Neil Sadick Presents on Pyratine-6 at the Annual Meeting of the American Academy of Dermatology
February 7, 2008
- EpiCept Announces Encouraging Results of Phase II Trial for NP-1 Cream in Diabetic Peripheral Neuropathy
- Genes as Time Machines
- Data From Anthera's Plasma Trial to be Presented as Late Breaker at American College Of Cardiology Scientific Sessions
- ADVENTRX to Present Complete ANX-530 Pharmacokinetic Data at the 2008 American Association for Cancer Research Annual Meeting
- IDX899 Demonstrates Rapid and Profound Inhibition of HIV Replication in a Phase I/II Clinical Trial in Treatment-Naive HIV-Infected Patients
- Pfizer Presents New Data from HIV/AIDS Portfolio at Conference on Retroviruses and Opportunistic Infections
- Merck's Isentress (raltegravir) Tablets in Combination with other Anti-HIV Medicines Maintained Reductions in HIV-1 Viral Load and Increased CD4 Cell Counts Through 48 Weeks of Therapy in Treatment-Experienced Adults
- CASTLE Study Showed Similar Efficacy Between Once-Daily Reyataz (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients
- Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients
- VIRxSYS Announces Interim Results from VRX496 Gene Therapy Phase II Trial
- Theratechnologies Presents Additional Results from Its Tesamorelin 52-week Phase 3 study at the Conference on Retroviruses and Opportunistic Infections
- Bevirimat Data Presented at 15th Conference on Retroviruses and Opportunistic Infections
- EpiCept Announces Encouraging Results of Phase II Trial for NP-1 Cream in Diabetic Peripheral Neuropathy
- Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
- Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
- New 48-Week Efficacy and Safety Data Presented for Intelence (etravirine) as Part of HIV Combination Therapy
- GeoVax Labs, Inc.'s Promising HIV/AIDS Vaccine Trial Data Presented at Retrovirus Conference
- Novelos Therapeutics and MUSC Abstract Accepted for Presentation at 2008 AACR Annual Meeting
- DNA Predicts Reaction to Drug That Fights Alcohol Dependence
- Amdoxovir plus Zidovudine Demonstrates Potent Antiviral Activity in HIV-Infected Patients
- Positive Results from Phase III Trial of Gamunex in Patients with CIDP
- Sustained High Efficacy of Gardasil Against Precancerous Cervical Lesions Confirmed in Longest Follow-up of Large Phase III Studies
- QSB Anti-Virulence Platform Inhibits Biofilm Formation by Staphylococcus Aureus MRSA and Candida sp
- Inhibitex HIV Integrase Inhibitor Data Presented at 15th Annual Conference on Retroviruses and Opportunistic Infections
- Alnylam Reports Pre-clinical Progress with RNAi Therapeutics in Neurological Disease
- Physicians Reconsider Implications of Enhance Trial
February 8, 2008
- Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
- American Heart Association Themed Issue Journal Report: Journal Edition Dedicated to Women's Unique Hypertension Issues
- InNexus Biotechnology Announces Preliminary Results of Animal Study Comparing Cancer Killing Activity of Its DXL625 (CD20) Treatment for Non-Hodgkin's Lymphoma With Leading Marketed Product
- Aprotinin and Ace Inhibitors During Off-Pump Cardiac Surgery Associated with Postoperative Renal Dysfunction
- Human Activity and Climate Change Could Aid Spread of Flaviviruses
- Discovery of New Gene Locus Associated with LDL-cholesterol Levels Could Lead to New Treatments
- Clinical Experience With Peregrine's Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
- InNexus Biotechnology Inc. To Host A Webcast Teleconference Detailing Recent News on Royalty Pharma Agreement & Preliminary Results of DXL625 Animal Study
- Gene Variant Predicts Medication Response in Patients with Alcohol Dependence
February 11, 2008
- New Data Shows Davanat Extends Survival of End-Stage Colorectal Cancer Patients More Than 6 Months
- BioDelivery Sciences to Present BEMA Fentanyl Data at the 24th Annual Meeting of the American Academy of Pain Medicine
- Genetic Immunity Presents Clinical Data on DermaVir Patch Immune Therapy at 15th Annual Conference on Retroviruses and Opportunistic Infections
- Bentley Pharmaceuticals Announces Completion of Treatment in Phase II India Clinical Study in Type 2 Diabetes and Preliminary Clinical Results
- Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
- Pixantrone Shows Activity in a Preclinical Study of Experimental Autoimmune Myasthenia Gravis (EAMG)
- Clavis Pharma Successfully Completes Clinical Phase I Study in Haematology
- Novel anti-CD20 monoclonal antibody ofatumumab demonstrates anti-tumour responses in patients with relapsed/refractory B-cell chronic lymphocytic leukaemia
- Advanced Cell Technology Announces Presentation of Results from Myoblast Study at ISCTR World Symposium
- AGI Dermatics Data Indicates 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1, Increases Collagen and Enhances DNA Repair
- AGI Dermatics Clinical Data Identifies L-Ergothioneine as Part of Skin's Natural Antioxidant System
- AGI Dermatics Clinical Data Indicate Bicyclic Monoterpene Diols Suppress MMP1 and Stimulate Collagen Through TNF-a Signaling
February 12, 2008
- Compugen Announces In-Vivo Results for Two Novel Peptide Agonists of MAS GPCR for Potential Treatment of Cardiovascular Pathologies
- Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
- Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations
- Biovitrum has Completed an Exploratory Clinical Phase II Study in Glaucoma
- Ipsen: Clinical Update For Decapeptyl 6-Month Formulation in Advanced Prostate Cancer
- New Survey Shows African-Americans Are Concerned With Heart Health but Unaware of Link to Brain Health
- Hana Biosciences Announces Top-Line Phase 1 Clinical Trial Data Demonstrating Alocrest to be Well-Tolerated With Promising Anti-Tumor Activity
- Depomed Reports Positive Efficacy Data From a Phase 2 Trial of Gabapentin GR in the Treatment of Menopausal Hot Flashes
- Valeant Pharmaceuticals Reports Positive Phase III Results for Retigabine in RESTORE 1
- Iomai Study Shows Self-Applied Travelers' Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch
- 2008 is a Decisive Year for the Validation of the Asthma Target Interleukin-13
- Patch Instead of Pills Makes Living with Alzheimer's Disease Easier
February 13, 2008
- ARIUS Presents New Findings Showing Therapeutic Antibody Inhibits Human Leukemic Cancer Stem Cells
- DOR BioPharma Announces Positive New Pulmonary Effect Data from orBec Clinical Trials
- Cytheris Announces 48-Week Results of Phase I/II Study Showing Administration of Interleukin-7 (IL-7) Significantly Improves CD4 T-Cell Counts in Chronically Infected HIV-1 Patients
- Avado Study of Avastin Plus Docetaxel Chemotherapy Showed Improved Progression-Free Survival in Patients With Advanced Breast Cancer
- AVADO Study of Avastin Plus Docetaxel Chemotherapy Showed Improved Progression-Free Survival in Patients with Advanced Breast Cancer
- Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
- Protox to Present Prostate Cancer Data at ASCO Conference
- VEGF Neutralization Can Damage Brain Vessels, Say Schepens Eye Research Institute Scientists
- Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
- Cytheris Announces 48-Week Results of Phase I/II Study Showing Administration of Interleukin-7 (IL-7) Significantly Improves CD4 T-Cell Counts in Chronically Infected HIV-1 Patients
- Publication of Data Concerning CAVATAK in Breast Cancer
- Unique Treatment for Alzheimer's Disease Improves Behavioural Symptoms for Patients - Ebixa Can Provide Benefits Alone or in Combination
- Marshfield Clinic Discovers Gene Variant Which Will Significantly Enhance the Accuracy of Molecular Tests for Warfarin Metabolism
February 14, 2008
- Dendreon Presents Data Correlating the Cumulative Potency of Provenge to Overall Survival
- Elite Pharmaceuticals, Inc. to Present Clinical Data at the American Academy of Pain Medicine's 24th Annual Meeting
- Solagran Limited Announce Unexpected Efficacy of Ropren in Treating Severe Alcoholism
- Data from Two Pivotal Trials of Amrix, a New Once-Daily Extended-Release Muscle Relaxant, Presented at the American Academy of Pain Medicine Meeting
- SJTRI Scientists Present Newest Research on Drug-Eluting Stents (DES)
- Cougar Biotechnology Presents Positive CB7630 Phase I and Phase II Data at ASCO 2008 Genitourinary Cancers Symposium
February 15, 2008
- Intra-Cellular Therapies Presents Data on Its Schizophrenia and Cognition in Schizophrenia Programs at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders
- Medical Therapies Limited Announce Positive Interim Results From Cuprindo Phase I Clinical Trials
- Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
- OncoGenex Reports Lead Drug Candidate OGX-011 Achieved Primary Endpoint in Phase 2 Trial with Second-Line Chemotherapy for Prostate Cancer
- Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
- Medical Therapies Limited (ASX:MTY) Announce Positive Interim Results From Cuprindo Phase I Clinical Trials
- Oncoproteins Double-Team and Destroy Vital Tumor-Suppressor
- Novel Approach Strips Staph of Virulence
- Higher Body Mass Index Means Higher Risk of Several Cancers
- Cougar Biotechnology Announces Presentation of Positive CB7630 Phase I Clinical Data at ASCO 2008 Genitourinary Cancers Symposium
February 19, 2008
- Bayer and Onyx Provide Update on Phase 3 Trial of Nexavar in Patients With Non-Small Cell Lung Cancer
- Nanoviricides Found Highly Effective Against Ebola by USAMRIID
- Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin
- Drug Reduces Airway Mucus in Preclinical Asthma Model
- Plexxikon Announces Publication of Key Data Demonstrating Possible Personalized Medicine for a Variety of Cancers
- Callisto Announces Guanilib Presentation at the 5th Annual Meeting of Cancer Drugs Research and Development
- InNexus Biotechnology Announces Second Preclinical CandidateDXL702 (HER2/neu) Targeting Breast Cancer
- Can-Fite Initiated Phase I Clinical Trial With CF102 First Cohort Was Successfully Completed
- JADO Reports Clinical Proof of Concept With Raft Modulator in Atopic Dermatitis
- Giaconda - Clinical Phase Pilot Study Results
February 20, 2008
- Antigenics Announces Publication of Phase 3 Melanoma Study Results in Journal of Clinical Oncology
- Phase I and Phase I/II DCVax-Brain Data Continues to Show Significantly Improved Survival Rates for Brain Cancer Patients
- Plexxikon Announces Publication of Key Data Demonstrating Possible Personalized Medicine for a Variety of Cancers
- Acrux Reports Compelling Results of Market Research on Testosterone MD-Lotion
- Sirtris Pharmaceuticals Co-Founder Presents First In-Vivo, Preclinical Data Showing SIRT1 Activation Can Suppress Tumor Formation and Growth
- Smoking's Effects on Genes May Play a Role in Lung Cancer Development and Survival
- Bausch & Lomb Announces Positive Clinical Results for Zylet in a Comparison of Safety and Efficacy with Tobradex in the Treatment of Blepharokeratoconjunctivitis
- Stress Hormone Impacts Memory, Learning in Diabetic Rodents
- Nymox's NX-1207 Offers a New and Attractive Approach to the Treatment of Benign Prostatic Hyperplasia
- Novocell Reports Successful Use of Stem Cells to Generate Insulin in Mice
February 21, 2008
- StemCyte Presents Six Abstracts on the Applications of Plasma-Depleted Umbilical Cord Blood Stem Cell Products at BMT Tandem Meetings
- Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
- Pre-Clinical Data Show Intracellular Pathways Affected by Onconase
- Dr. Mark Nestor Presents on Pyratine-6 at the South Beach Symposium
- Advanced Cell Technology Demonstrates Efficient Generation of Functional Hepatocytes (Liver Cells) From Human Embryonic Stem Cells
February 25, 2008
- Top-Line Results From Pivotal Phase 3 MEND-CABG II Clinical
- Ipsen: Toremifene Citrate 80 mg Meets Primary and Key Secondary Endpoints in Phase III Clinical Trial in Advanced Prostate Cancer Patients on Androgen Deprivation Therapy
- CV Therapeutics Announces Presentations at the American College of Cardiology 57th Annual Scientific Session
- MacuSight Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration
- Orion OYJ: GTx Announced Phase III Clinical Data for Toremifene Citrate 80 mg
- GTx's Toremifene Citrate 80 mg Meets Primary and Key Endpoints in Phase III Trial in Advanced Prostate Cancer Patients on Androgen Deprivation Therapy
- Publication of Data concerning Cavatak and Evatak in Prostate Cancer
- Elixir Pharmaceuticals Presents New Data on Ghrelin Inhibition at Keystone Meeting
- NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
- Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
- ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom Combination Therapy with Lucentis
- Oncothyreon's PX-478 is Effective in Preclinical Model of Human Lung Cancer
February 26, 2008
- ARIUS Announces Five Abstracts Selected for Presentation at 2008 AACR Annual Meeting
- Bradmer Announces Phase II Results Published in Newly Diagnosed Glioblastoma which Demonstrate Improved Survival and Support Upcoming Phase III Study
- Lux Biosciences to Provide Update on Four Pipeline Programs, Including Two Phase 3 Clinical Programs, at ARVO
- Prana Announces Success in Phase IIa Clinical Trial of PBT2 in Early Alzheimer's
- Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
- Eurand Announces Positive Pharmacokinetic Study Results of Once-a-Day Ondansetron
- Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
- Data on PolyMedix Antimicrobial Polymers Presented at American Society of Microbiology 6th Annual Biodefense and Emerging Diseases Research Meeting
- PrimeGen Biotech Announces Non-Viral Reprogramming of Human Cells into Stem Cells
- Pyratine-6 Study Published in Journal of Drugs in Dermatology
- Faster Chemo Technique Increases Survival in Children with Neuroblastoma
- Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks
- Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
February 27, 2008
- Oculus Innovative Sciences Announces Positive Top-Line Phase II Data with Microcyn Technology in Mildly Infected Diabetic Foot Ulcers
- Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks
- Intercell Completes Phase I Clinical Trial for an Improved Seasonal Influenza Vaccine Formulated with IC31
- Oculus Innovative Sciences Schedules Conference Call Today to Discuss Positive Top-Line Phase II Data with Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers
- Teens with Treatment-resistant Depression More Likely to Get Better with Switch to Combination Therapy
February 28, 2008
- XenoPort and GlaxoSmithKline Report Positive Top-Line Results of Final Pivotal Trial of XP13512/GSK1838262 for Restless Legs Syndrome
- NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
- Athersys Announces Summary Results for Phase 1 Safety Study of Its Novel Obesity Drug
- Dr. Gabriel Sosne to Present New TB4 Anti-Inflammation Data at ARVO
- Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
- PAION's Anticoagulant Solulin Successfully Tested in First-in-man Study
- Intravenous Immunoglobulin Treatment is Associated with a Reduced Risk of Developing Alzheimer's Disease and Related Disorders
- Biothera Drug Synergistic with Avastin Against Cancer, Study Finds
- NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit
February 29, 2008
- Inhibiton Therapeutics' Testing of ICA-1 Compound Continues to Progress
- Avontec Announce Results of a Multiple Dose Clinical Proof of Concept Study with Its Drug Candidate AVT-01 Decoy ODN in Asthmatic Patients
- Alnylam Achieves First Human Proof of Concept for an RNAi Therapeutic with GEMINI Study
- Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone)
- Liver Phase I Abstract Presented at 8th World Congress of IHPBA
- InvestBio Portfolio Company Presents Phase I/II Trial Results of Vaccine for Leukemia at American Society of Hematology Annual Meeting
- Mayo Researchers Look for Explanation Behind High Incidence of Diabetes Among Asian Indians
